BIOMAT Database Logo BIOMAT Database Logo

Propranolol disposition in cirrhosis. 1985

D B Jones

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D B Jones
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings].
October 1977, British journal of clinical pharmacology,
D B Jones
Propranolol disposition in renal failure.
December 1980, British journal of clinical pharmacology,
D B Jones
Furosemide disposition in cirrhosis.
June 1982, Clinical pharmacology and therapeutics,
D B Jones
Disposition of propranolol isomers in mice.
November 1976, European journal of pharmacology,
D B Jones
Antipyrine and propranolol disposition in malnutrition.
January 1978, East African medical journal,
D B Jones
Propranolol and cirrhosis.
July 1985, Lancet (London, England),
D B Jones
Biological determinants of propranolol disposition in man.
February 1978, Clinical pharmacology and therapeutics,
D B Jones
Disposition of propoxyphene and propranolol in children.
March 1976, Clinical pharmacology and therapeutics,
D B Jones
Age and propranolol stereoselective disposition in humans.
May 1992, Clinical pharmacology and therapeutics,
D B Jones
Propranolol disposition in patients with hepatosplenic schistosomiasis.
September 1987, British journal of clinical pharmacology,
Copied contents to your clipboard!